ArticleRegenerative biomaterials2025
Magnesium phosphate functionalized graphene oxide and PLGA composite matrices with enhanced mechanical and osteogenic properties for bone regeneration.
Article in Regenerative biomaterials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Graphene oxide coating on two-dimensional glass substrates and three-dimensional zirconia scaffolds for bone tissue regeneration.Materials today. Bio · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone defects affect millions of people annually, making bone tissue of particular interest for developing treatments. Current strategies for healing suffer drawbacks. Regenerative engineering seeks to achieve efficient bone regeneration by utilizing synthetic bone grafts to evade these drawbacks. One material that offers such benefits is a class of functional graphenic material, known as Phosphate Graphenes. While many of our studies have focused on Calcium Phosphate Graphene, magnesium is also osteogenic. Therefore, in this study, we utilized regenerative engineering techniques to incorporate Magnesium Phosphate Graphene (MgPG) into poly(lactic-co-glycolic acid) (PLGA) to fabricate composite microsphere-based matrices as a potential synthetic bone graft. Employing different amounts of MgPG within PLGA matrices, we studied the effect of MgPG on the morphological, structural, physical and biological characteristics. MgPG-containing matrices demonstrated great mechanical strength, hydrophilicity and degradability without compromising matrix morphology. Because MgPG is a graphene oxide derivative with magnesium and phosphate ions capable of supporting bone healing as inducerons, we next evaluated the cytocompatibility and osteogenic potential of these PLGA/MgPG composite matrices. MgPG matrices demonstrated high cell viability and proliferation of MC3T3-E1 cells as well as increased osteogenic activity reported by alkaline phosphatase activity, calcium deposition and gene expression of Col1a1, osteocalcin, bone sialoprotein and Sp7. Lastly, we investigated the gene expression profile of markers/targets of the canonical β-catenin dependent Wnt signaling pathway with and without inhibitor DKK1 to understand the potential underlying mechanism behind the enhanced osteogenic potential of MgPG. In response to MgPG, gene expression of β-catenin increased, while protein expression of BMP-2 and WISP-1 also increased. These results suggest the influence of MgPG on the Wnt pathway in relation to osteogenic differentiation. With further study, MgPG matrices may provide practical solutions to the problem of effectively regenerating critical-sized bone defects, which remains a challenge in orthopaedics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.